SCHEMBL10201817

SCHEMBL10201817

Cc1ccc(-c2ncc(-c3ccc4nc([C@@H]5CCCN5C(=O)Cc5ccccc5)[nH]c4c3)o2)cc1NC(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.39
PRCP P42785 4/20 0.38
HCRTR1 O43613 10/20 0.37
HCRTR2 O43614 10/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10202513 0.95 KCNH2 (0.46) KCNH2PRCPHCRTR1HCRTR2CYP1A2
SCHEMBL10201814 0.95 PRCP (0.38) KCNH2PRCPHCRTR1HCRTR2
SCHEMBL10201558 0.92 HCRTR1 (0.41) HCRTR1HCRTR2
SCHEMBL12374131 0.90 KCNH2 (0.49) KCNH2HCRTR1HCRTR2CYP1A2CYP3A4
SCHEMBL10202512 0.89 HCRTR1 (0.40) PRCPHCRTR1HCRTR2
SCHEMBL12374143 0.89 PRCP (0.38) KCNH2PRCPHCRTR1HCRTR2
SCHEMBL10202511 0.88 HCRTR1 (0.39) HCRTR1HCRTR2
SCHEMBL10202423 0.88 HCRTR1 (0.43) KCNH2PRCPHCRTR1HCRTR2CYP1A2
SCHEMBL2276767 0.87 KCNH2 (0.48) KCNH2PRCPCYP1A2CYP3A4CYP2D6
SCHEMBL2278820 0.87 KCNH2 (0.48) KCNH2PRCPCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed